SlideShare a Scribd company logo
1 of 31
INHALANT(VOLATILE) USE DISORDER
AND
NICOTINE ABUSE
Presentation by : Arshid Ahmad
B.Sc Nursing 3rd year, MMINSR, SKIMS
Contents
• INHALANT USE DISORDER
• Introduction
• Defnition
• Commonly used inhalants
• Epidemiology
• Methods of use
• Clinical effects
• Intoxication
• Tolerance and dependence
• Complications
• Diagnosis
• Managment-medical and nursing
• Nicotine abuse
• Introduction
• Defnition
• Addiction statistics
• Methods of use
• Symptoms
• Effects
• Intoxication
• Withdrawl symptoms
• Management- medical and nursing
Introduction
• Inhalant abuse – also known as volatile substance abuse, solvent abuse,
sniffing, huffing and bagging – is the deliberate inhalation of a volatile
substance to achieve an altered mental state.
• Inhalant use–related problems affect youths worldwide, particularly
socioeconomically disadvantaged children and adolescents .
• Inhalant use is a serious public health concern and has several adverse
medical consequences. It is associated with substantial cardiac, renal,
hepatic, and neurological morbidity and mortality.
DEFINITION
Inhalant use is defined as the deliberate inhalation of volatile
substances (e.g., glue, shoe polish, gasoline, paint, cleaning
fluids, amyl nitrite), either by sniffing, snorting, bagging, or
huffing the substance, in order to induce a psychoactive or mind-
altering effect.
What are Inhalants?
•Inhalants are legal, everyday products which have a useful
purpose, but can be misused.
. COMMONLY ABUSED INHALANTS
1. Volatile solvents: Includes Glues(toulene), correction fluids,
marker pens,paint thinners and removers,petrol etc.
2. Aerosols: Deodorants , hair sprays etc.
3. Gases: Butane , propane,ansthetic gases( nitrous oxide)
4. Nitritis
EPIDEMIOLOGY
•Volatile Substance Misuse is a worldwide problem. The
psychiatric morbidity survey(2009) suggests that in
households in England, lifetime use of volatile Substance
was about 1.4%.
•Amyl Nitrite (poppers) appears to be more commonly used.
•Volatile Substance Misuse is highly prevalent among the
young homeless population in south American countries.
•It is found mainly in men and is more common in individuals
from lower socioeconomic groups.
Methods of use
•The method of injestion depends on the substance used and
include inhalation from:
. ✓ Top of bottles
✓ Beer cans
✓ Cloths held over a mouth.
✓ Plastic bags
✓ Sprays
Clinical effects of inhalant abuse
Tolerance and dependence
1. Dependence can develop if its use is regular
2. Physical withdrawl symptoms
• Sleep disturbance
• Irritability
• Nausea
• Tachycardia
• Anxiety
• Hallicunations
• Dillusions
3. With sustained use over a period of 6-12 months tolerance can develop.
Complications
•Chronic users may show evidence of Neurotoxic effects.
•Severe and disabling peripheral neuropathy (in teenage
misusers).
•Impaired cerebral function.
•Encephalitis
•Dementia.
•It can also cause irreversible damage to liver, kidneys,heart and
brain.
•It increases the risk of accidents Due to hallucinations.
Diagnosis
✓It is suggested by Several features including
• Glue on the hands, face ,cloths.
• Chemical smell on breath.
• Rapid onset and waning of intoxication.
• Disorientation in time and space.
✓ Chronic misuse is diagnosed mainly on the basis of an admitted
history of habitual consumption, increasing tolerance and dependance.
✓ A suggestive feature is a Facial Rash(glue-Sniffers rash) caused by
repeated inhalation from a bag.
Management
General principles:
•Acute medical management(in case if intoxication)
•Detailed history (including product used, other substances and
psychiatric symptoms)
•Physical examination including detailed neurological
examination (especially chronic abusers)
•Lab investigation for liver and kidney and liver function, ECG.
•Pharmological management for withdrawal symptoms.
•Psychosocial interventions.
Pharmacotherapy
• Benzodiazepines like diazepam ( acute intoxication)
• Baclofen(around 50 mg/day)
• Buspirone(40 mg/day)
• Lamotrigine(100mg/day)
Psychosocial interventions
• Cognitive behaviour therapy:
• Motivational intervention:
• Family counseling:
• Activity and engagment Programmes:
Nurses Role
• Teach the family about the inhalant abuse and it’s effects on entire family
• Meeting the potential health problems and nutrition advice to patients and
families.
• Nurses meet the basic needs like safety, hygiene, comfort,calm and quite
environment of the patients.
• Adminster substitution therapy
• Prompt interventions in emergencies like LOC and respiratory arrest.
• Monitoring withdrawal symptoms and their appropriate management.
• Teach the patient/family how to recognise psychosocial stressors that may
exacerbate inhalant abuse and how to avoid or prevent them.
• Teach patient/family about the availability of self help programs to strengthen
patient recovery.
INTRODUCTION
•Nicotine is found in the tobacco plant.
•Tobacco leaves are harvested while still green and undergo
curing and fermentation to produce commercial products–
cigarettes, cigars, snuffs, chewing tobacco and pipe Tobacco.
•Tobacco has many constituents, but nicotine has the broadest
and most immediate pharmacological action.
Definition
Nicotine is a colourless, toxic alkoliod made up of
carbon, hydrogen and nitrogen.
• The primary reason why Nicotine use have turned into Worldwide
concern is because of its ability to induce a state of Euphoria in the
brain of the smoker, thus leading to addiction.
• When a person smokes and inhales nicotine, the active substances
are absorbed through alveoli into the lungs which initiate chemical
reactions in the nerve endings which increases heart rate, Memory,
alertness and reaction time.
• Neurotransmitters called dopamine and later endorphins are
released in the brain producing feeling of pleasure and
satisfaction.
• As an addictive drug, Nicotine has two very potent issues- it is
a stimulant as well as depressent.
Addiction statistics
•Nicotine is used most often in the form of smoking.
•Tobacco addiction is the preventable cause of death in the US
and the second Leading cause of death in the world
•The WHO estimates that there are 1.3 billion smokers
worldwide today and contributes approx. 5 million deaths each
year.
•In India Among adults (age 15+), 28.6% of the population
currently uses tobacco products (men 42.4%; women 14.2%).
Among youth (ages 13–15): 8.5% currently use some form of
tobacco (boys 9.6%; girls 7.4%).
Methods of Nicotine Use
• Orally
• Sniffed
• Smoked( 90%)
• Others- Nicotine patches, gums.
Symptoms of Nicotine Use
•Tolerance to Nicotine with Decreased effect and increased dose
to obtain same effect.
•Withdrawal symptoms after cessation.
•Smoking more than usual.
•Extensive time spent smoking or purchasing tobacco.
•Postponing work,social or recreational events inorder to smoke.
•Continuity of smoke despite health hazards.
Physical and psychological effects of nicotine use
Physical effects:
✓ increased heartrate
✓ acclerated BP
✓weight loss
✓ decreased appetite
Psychological effects:
✓ Enhances Alertness
✓ Stimulate a frantic, almost Manic picture.
. ✓ relaxation
Nicotine intoxication
•Nausea.
•Vomiting.
•Salvation
•Pallor
•Abdominal pain
•Diarrhoea
• Cold sweat
• Arrythmias
• Shock
• Death
Withdrawal symptoms
•Cravings
•Irritability, anxiety and
depression
•Restlessness
•Weight gain
•Trouble concentrating
• Headache
•Coughing
•Sore throat
•Aches and pains
Diagnostic criteria for nicotine addiction
A. Daily use of nicotine for atleast several weeks.
B. Abrupt cessation of tobacco use, followed within 24 hours by four or more of the following
signs:
• Dysphoric or depressed mood
• Insomnia
• Irritability, frustration and anger
• Anxiety
• Difficulity concentrating
• Restlessness
• Decreased heartrate
• Increase appetite
C. The symptoms in the criterion B cause clinically significant impairment in social, occupational
and other important areas of functioning.
D. The symptoms are not due to a general medical condition.
Management
1. Nicotine replacement therapy:
. ✓Transdermal nicotine patches
✓Nasal sprays
✓Orally adminsterd products (nicotine gum, lozenge,inhaler)
2. Non-Nicotine therapies:
✓Bupiropian(300 mg/day: 150mg BID)
✓Verenicline
✓Nortriptyline
3. Novel therapies:
. ✓anti smoking vaccine (nic vax)
✓green smoke e-cigarette
• 4 Motivational therapies
• 5. Councelling
• 6. Aversion therapy
Treatment of Nicotine intoxication
•Benzodiazepines
•Iv fluids To treat low bp
•Ventilatory support
Nurses role
1. Client education and prevention of nicotine use.
2. Nurses are involved in each level of prevention
• Primary prevention
• Secondary prevention
• Teritary prevention
3. During acute episodes:
• Continuously moniter the patients vital signs And input/output
• Watch for complications of withdrawal and Overdose
• Maintain a quite and safe environment
• Approach the patient in non threatening way.
•Adminster IV fluids to increase circulatory volume
•Give medication as ordered
•Teach the patient/family About Local self help groups to
strengthen patients recovery
•During withdrawal
•Adminster medication as ordered, to decrease withdrawal
symptoms, moniter and record their effectiveness.
•Maintain a quite safe environment because excessive may
agitate the patient.
Inhalant use disorder.pptx

More Related Content

What's hot

What's hot (20)

Substance use disorder
Substance use disorderSubstance use disorder
Substance use disorder
 
Neuroleptic malignant syndrome
Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Neuroleptic malignant syndrome
 
Psychotropic drugs
Psychotropic drugsPsychotropic drugs
Psychotropic drugs
 
Affective disorders
Affective disordersAffective disorders
Affective disorders
 
De addiction
De addictionDe addiction
De addiction
 
Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)
 
Common withdrawal syndromes and management
Common withdrawal syndromes and managementCommon withdrawal syndromes and management
Common withdrawal syndromes and management
 
Assessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorderAssessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorder
 
Substance use in children and adolescent
Substance use in children and adolescentSubstance use in children and adolescent
Substance use in children and adolescent
 
Clozapine
ClozapineClozapine
Clozapine
 
Lithium Toxicity
Lithium ToxicityLithium Toxicity
Lithium Toxicity
 
Cocaine Use Disorder- Psychiatric Nursing
Cocaine Use Disorder- Psychiatric NursingCocaine Use Disorder- Psychiatric Nursing
Cocaine Use Disorder- Psychiatric Nursing
 
Major depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationMajor depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentation
 
Bipolar disorder management
Bipolar disorder managementBipolar disorder management
Bipolar disorder management
 
Mania
ManiaMania
Mania
 
stimulants
stimulantsstimulants
stimulants
 
Catatonia and neuroleptic malignant syndrome
Catatonia and neuroleptic malignant syndromeCatatonia and neuroleptic malignant syndrome
Catatonia and neuroleptic malignant syndrome
 
Metabolic side effects of drugs in Psychiatry
Metabolic side effects of drugs in PsychiatryMetabolic side effects of drugs in Psychiatry
Metabolic side effects of drugs in Psychiatry
 
Management suicide
Management suicideManagement suicide
Management suicide
 
Bipolar mood disorder
Bipolar mood disorder Bipolar mood disorder
Bipolar mood disorder
 

Similar to Inhalant use disorder.pptx

Tobacco use disorder.pptx
Tobacco use disorder.pptxTobacco use disorder.pptx
Tobacco use disorder.pptxcorbettaRDC
 
2_5406982690266162591.pptx
2_5406982690266162591.pptx2_5406982690266162591.pptx
2_5406982690266162591.pptxKirkukHatem
 
MNS Care for MO- Substance Use Disorders (SUDs).pptx
MNS Care for MO- Substance Use Disorders (SUDs).pptxMNS Care for MO- Substance Use Disorders (SUDs).pptx
MNS Care for MO- Substance Use Disorders (SUDs).pptxhtmii
 
World No Tobacco Day 2020
World No Tobacco Day 2020 World No Tobacco Day 2020
World No Tobacco Day 2020 amithash
 
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin JOpioid Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin J
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin JJuhin J
 
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin JInhalant Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin J
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin JJuhin J
 
Seminar on Addiction and Substance use
Seminar on Addiction and Substance useSeminar on Addiction and Substance use
Seminar on Addiction and Substance useDr Rakesh Verma
 
Nicotine toxicity
Nicotine toxicityNicotine toxicity
Nicotine toxicityreiamameer
 
The Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and TherapyThe Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and Therapyyvettelopez21
 
Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.yvettelopez21
 
4.DRUG and SUBSTANCE ABUSE.ppt
4.DRUG and SUBSTANCE ABUSE.ppt4.DRUG and SUBSTANCE ABUSE.ppt
4.DRUG and SUBSTANCE ABUSE.pptIanHenry26
 
Smoking prevention and cessation
Smoking prevention and cessationSmoking prevention and cessation
Smoking prevention and cessationReynel Dan
 
Substance abuse and dependence
Substance abuse and dependenceSubstance abuse and dependence
Substance abuse and dependenceReynel Dan
 
Substance abuse- Theory and Practice.
Substance abuse- Theory and Practice. Substance abuse- Theory and Practice.
Substance abuse- Theory and Practice. Aaradhana Reddy
 

Similar to Inhalant use disorder.pptx (20)

Tobacco use disorder.pptx
Tobacco use disorder.pptxTobacco use disorder.pptx
Tobacco use disorder.pptx
 
2_5406982690266162591.pptx
2_5406982690266162591.pptx2_5406982690266162591.pptx
2_5406982690266162591.pptx
 
MNS Care for MO- Substance Use Disorders (SUDs).pptx
MNS Care for MO- Substance Use Disorders (SUDs).pptxMNS Care for MO- Substance Use Disorders (SUDs).pptx
MNS Care for MO- Substance Use Disorders (SUDs).pptx
 
World No Tobacco Day 2020
World No Tobacco Day 2020 World No Tobacco Day 2020
World No Tobacco Day 2020
 
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin JOpioid Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin J
Opioid Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
 
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin JInhalant Use Disorder | Substance Abuse | Psychiatric Nursing |  Juhin J
Inhalant Use Disorder | Substance Abuse | Psychiatric Nursing | Juhin J
 
Seminar on Addiction and Substance use
Seminar on Addiction and Substance useSeminar on Addiction and Substance use
Seminar on Addiction and Substance use
 
Delirium disorder
Delirium disorderDelirium disorder
Delirium disorder
 
Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
 
Nicotine toxicity
Nicotine toxicityNicotine toxicity
Nicotine toxicity
 
Substance abuse. ajb
Substance abuse. ajbSubstance abuse. ajb
Substance abuse. ajb
 
The Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and TherapyThe Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and Therapy
 
Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.
 
4.DRUG and SUBSTANCE ABUSE.ppt
4.DRUG and SUBSTANCE ABUSE.ppt4.DRUG and SUBSTANCE ABUSE.ppt
4.DRUG and SUBSTANCE ABUSE.ppt
 
Smoking prevention and cessation
Smoking prevention and cessationSmoking prevention and cessation
Smoking prevention and cessation
 
De addiction
De addiction De addiction
De addiction
 
Drug of Abuse
Drug of AbuseDrug of Abuse
Drug of Abuse
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Substance abuse and dependence
Substance abuse and dependenceSubstance abuse and dependence
Substance abuse and dependence
 
Substance abuse- Theory and Practice.
Substance abuse- Theory and Practice. Substance abuse- Theory and Practice.
Substance abuse- Theory and Practice.
 

Recently uploaded

Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 

Recently uploaded (20)

Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 

Inhalant use disorder.pptx

  • 1. INHALANT(VOLATILE) USE DISORDER AND NICOTINE ABUSE Presentation by : Arshid Ahmad B.Sc Nursing 3rd year, MMINSR, SKIMS
  • 2. Contents • INHALANT USE DISORDER • Introduction • Defnition • Commonly used inhalants • Epidemiology • Methods of use • Clinical effects • Intoxication • Tolerance and dependence • Complications • Diagnosis • Managment-medical and nursing • Nicotine abuse • Introduction • Defnition • Addiction statistics • Methods of use • Symptoms • Effects • Intoxication • Withdrawl symptoms • Management- medical and nursing
  • 3. Introduction • Inhalant abuse – also known as volatile substance abuse, solvent abuse, sniffing, huffing and bagging – is the deliberate inhalation of a volatile substance to achieve an altered mental state. • Inhalant use–related problems affect youths worldwide, particularly socioeconomically disadvantaged children and adolescents . • Inhalant use is a serious public health concern and has several adverse medical consequences. It is associated with substantial cardiac, renal, hepatic, and neurological morbidity and mortality.
  • 4. DEFINITION Inhalant use is defined as the deliberate inhalation of volatile substances (e.g., glue, shoe polish, gasoline, paint, cleaning fluids, amyl nitrite), either by sniffing, snorting, bagging, or huffing the substance, in order to induce a psychoactive or mind- altering effect.
  • 5. What are Inhalants? •Inhalants are legal, everyday products which have a useful purpose, but can be misused. . COMMONLY ABUSED INHALANTS 1. Volatile solvents: Includes Glues(toulene), correction fluids, marker pens,paint thinners and removers,petrol etc. 2. Aerosols: Deodorants , hair sprays etc. 3. Gases: Butane , propane,ansthetic gases( nitrous oxide) 4. Nitritis
  • 6. EPIDEMIOLOGY •Volatile Substance Misuse is a worldwide problem. The psychiatric morbidity survey(2009) suggests that in households in England, lifetime use of volatile Substance was about 1.4%. •Amyl Nitrite (poppers) appears to be more commonly used. •Volatile Substance Misuse is highly prevalent among the young homeless population in south American countries. •It is found mainly in men and is more common in individuals from lower socioeconomic groups.
  • 7. Methods of use •The method of injestion depends on the substance used and include inhalation from: . ✓ Top of bottles ✓ Beer cans ✓ Cloths held over a mouth. ✓ Plastic bags ✓ Sprays
  • 8. Clinical effects of inhalant abuse
  • 9.
  • 10. Tolerance and dependence 1. Dependence can develop if its use is regular 2. Physical withdrawl symptoms • Sleep disturbance • Irritability • Nausea • Tachycardia • Anxiety • Hallicunations • Dillusions 3. With sustained use over a period of 6-12 months tolerance can develop.
  • 11. Complications •Chronic users may show evidence of Neurotoxic effects. •Severe and disabling peripheral neuropathy (in teenage misusers). •Impaired cerebral function. •Encephalitis •Dementia. •It can also cause irreversible damage to liver, kidneys,heart and brain. •It increases the risk of accidents Due to hallucinations.
  • 12. Diagnosis ✓It is suggested by Several features including • Glue on the hands, face ,cloths. • Chemical smell on breath. • Rapid onset and waning of intoxication. • Disorientation in time and space. ✓ Chronic misuse is diagnosed mainly on the basis of an admitted history of habitual consumption, increasing tolerance and dependance. ✓ A suggestive feature is a Facial Rash(glue-Sniffers rash) caused by repeated inhalation from a bag.
  • 13. Management General principles: •Acute medical management(in case if intoxication) •Detailed history (including product used, other substances and psychiatric symptoms) •Physical examination including detailed neurological examination (especially chronic abusers) •Lab investigation for liver and kidney and liver function, ECG. •Pharmological management for withdrawal symptoms. •Psychosocial interventions.
  • 14. Pharmacotherapy • Benzodiazepines like diazepam ( acute intoxication) • Baclofen(around 50 mg/day) • Buspirone(40 mg/day) • Lamotrigine(100mg/day) Psychosocial interventions • Cognitive behaviour therapy: • Motivational intervention: • Family counseling: • Activity and engagment Programmes:
  • 15. Nurses Role • Teach the family about the inhalant abuse and it’s effects on entire family • Meeting the potential health problems and nutrition advice to patients and families. • Nurses meet the basic needs like safety, hygiene, comfort,calm and quite environment of the patients. • Adminster substitution therapy • Prompt interventions in emergencies like LOC and respiratory arrest. • Monitoring withdrawal symptoms and their appropriate management. • Teach the patient/family how to recognise psychosocial stressors that may exacerbate inhalant abuse and how to avoid or prevent them. • Teach patient/family about the availability of self help programs to strengthen patient recovery.
  • 16.
  • 17. INTRODUCTION •Nicotine is found in the tobacco plant. •Tobacco leaves are harvested while still green and undergo curing and fermentation to produce commercial products– cigarettes, cigars, snuffs, chewing tobacco and pipe Tobacco. •Tobacco has many constituents, but nicotine has the broadest and most immediate pharmacological action.
  • 18. Definition Nicotine is a colourless, toxic alkoliod made up of carbon, hydrogen and nitrogen. • The primary reason why Nicotine use have turned into Worldwide concern is because of its ability to induce a state of Euphoria in the brain of the smoker, thus leading to addiction. • When a person smokes and inhales nicotine, the active substances are absorbed through alveoli into the lungs which initiate chemical reactions in the nerve endings which increases heart rate, Memory, alertness and reaction time.
  • 19. • Neurotransmitters called dopamine and later endorphins are released in the brain producing feeling of pleasure and satisfaction. • As an addictive drug, Nicotine has two very potent issues- it is a stimulant as well as depressent.
  • 20. Addiction statistics •Nicotine is used most often in the form of smoking. •Tobacco addiction is the preventable cause of death in the US and the second Leading cause of death in the world •The WHO estimates that there are 1.3 billion smokers worldwide today and contributes approx. 5 million deaths each year. •In India Among adults (age 15+), 28.6% of the population currently uses tobacco products (men 42.4%; women 14.2%). Among youth (ages 13–15): 8.5% currently use some form of tobacco (boys 9.6%; girls 7.4%).
  • 21. Methods of Nicotine Use • Orally • Sniffed • Smoked( 90%) • Others- Nicotine patches, gums.
  • 22. Symptoms of Nicotine Use •Tolerance to Nicotine with Decreased effect and increased dose to obtain same effect. •Withdrawal symptoms after cessation. •Smoking more than usual. •Extensive time spent smoking or purchasing tobacco. •Postponing work,social or recreational events inorder to smoke. •Continuity of smoke despite health hazards.
  • 23. Physical and psychological effects of nicotine use Physical effects: ✓ increased heartrate ✓ acclerated BP ✓weight loss ✓ decreased appetite Psychological effects: ✓ Enhances Alertness ✓ Stimulate a frantic, almost Manic picture. . ✓ relaxation
  • 25. Withdrawal symptoms •Cravings •Irritability, anxiety and depression •Restlessness •Weight gain •Trouble concentrating • Headache •Coughing •Sore throat •Aches and pains
  • 26. Diagnostic criteria for nicotine addiction A. Daily use of nicotine for atleast several weeks. B. Abrupt cessation of tobacco use, followed within 24 hours by four or more of the following signs: • Dysphoric or depressed mood • Insomnia • Irritability, frustration and anger • Anxiety • Difficulity concentrating • Restlessness • Decreased heartrate • Increase appetite C. The symptoms in the criterion B cause clinically significant impairment in social, occupational and other important areas of functioning. D. The symptoms are not due to a general medical condition.
  • 27. Management 1. Nicotine replacement therapy: . ✓Transdermal nicotine patches ✓Nasal sprays ✓Orally adminsterd products (nicotine gum, lozenge,inhaler) 2. Non-Nicotine therapies: ✓Bupiropian(300 mg/day: 150mg BID) ✓Verenicline ✓Nortriptyline 3. Novel therapies: . ✓anti smoking vaccine (nic vax) ✓green smoke e-cigarette
  • 28. • 4 Motivational therapies • 5. Councelling • 6. Aversion therapy Treatment of Nicotine intoxication •Benzodiazepines •Iv fluids To treat low bp •Ventilatory support
  • 29. Nurses role 1. Client education and prevention of nicotine use. 2. Nurses are involved in each level of prevention • Primary prevention • Secondary prevention • Teritary prevention 3. During acute episodes: • Continuously moniter the patients vital signs And input/output • Watch for complications of withdrawal and Overdose • Maintain a quite and safe environment • Approach the patient in non threatening way.
  • 30. •Adminster IV fluids to increase circulatory volume •Give medication as ordered •Teach the patient/family About Local self help groups to strengthen patients recovery •During withdrawal •Adminster medication as ordered, to decrease withdrawal symptoms, moniter and record their effectiveness. •Maintain a quite safe environment because excessive may agitate the patient.